- Home
- CDNA vs KALU Comparison
CDNA vs KALU Comparison
Compare CDNA & KALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- KALU
- Stock Information
- Founded
- CDNA 1998
- KALU 1946
- Country
- CDNA United States
- KALU United States
- Employees
- CDNA N/A
- KALU N/A
- Industry
- CDNA Medical Specialities
- KALU Metal Fabrications
- Sector
- CDNA Health Care
- KALU Industrials
- Exchange
- CDNA Nasdaq
- KALU Nasdaq
- Market Cap
- CDNA 1.1B
- KALU 1.1B
- IPO Year
- CDNA 2014
- KALU 1991
- Fundamental
- Price
- CDNA $23.34
- KALU $70.25
- Analyst Decision
- CDNA Buy
- KALU Buy
- Analyst Count
- CDNA 8
- KALU 3
- Target Price
- CDNA $27.17
- KALU $82.33
- AVG Volume (30 Days)
- CDNA 642.2K
- KALU 97.7K
- Earning Date
- CDNA 02-26-2025
- KALU 02-19-2025
- Dividend Yield
- CDNA N/A
- KALU 4.37%
- EPS Growth
- CDNA N/A
- KALU 252.66
- EPS
- CDNA N/A
- KALU 2.90
- Revenue
- CDNA $312,775,000.00
- KALU $2,980,300,000.00
- Revenue This Year
- CDNA $19.85
- KALU N/A
- Revenue Next Year
- CDNA $11.34
- KALU $6.84
- P/E Ratio
- CDNA N/A
- KALU $24.26
- Revenue Growth
- CDNA 5.26
- KALU N/A
- 52 Week Low
- CDNA $7.42
- KALU $59.52
- 52 Week High
- CDNA $34.84
- KALU $102.42
- Technical
- Relative Strength Index (RSI)
- CDNA 56.42
- KALU 32.64
- Support Level
- CDNA $20.35
- KALU $69.37
- Resistance Level
- CDNA $21.68
- KALU $72.20
- Average True Range (ATR)
- CDNA 1.10
- KALU 2.35
- MACD
- CDNA 0.19
- KALU -0.15
- Stochastic Oscillator
- CDNA 99.09
- KALU 28.92
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About KALU Kaiser Aluminum Corporation
Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from United States.